Across investor & stakeholder communications, clinical development, regulatory affairs, commercial strategy, market access, corporate finance, M&A, and IPO.
Clinical Development & Marketing Strategy
A seasoned pharmaceutical physician with over 30 years of experience across Big Pharma and biotech sectors. Malcolm’s expertise spans the entire development lifecycle from Phase I–III across multiple therapeutic categories with special emphasis in Women’s Health. Malcolm has also built and successfully exited three Life Science companies. Other areas of focus include accelerating patient recruitment and implementing digital marketing strategies (DTC/EHR) for clinical and commercial success.
Founder, CEO, CSO, COO & Board Member
Scientist-entrepreneur bridging the gap between bench research and boardroom strategy. Deep expertise in product development, clinical trial design (P0–P3), AI, M&A sourcing, diagnostics, drug delivery, and biotech operations. Brings a hands-on operator mindset to accelerating scientific innovation into market value.
CCO
CCO that closes the clinical-to-commercial gap. Biopharma CCO and commercial architect with 25+ years building the engines that take products from clinical hypothesis to launch. Personally led or co-led launches generating $1B+ in annual revenue. Built commercial organizations from the ground up at four companies. Core differentiator: I enter at the TPP stage — shaping endpoints, strengthening labels, and de-risking downstream commercialization before most commercial executives arrive
M&A, Partnering & Strategic Financing
A finance veteran with over 27 years of experience in Private Equity, Venture Capital, and strategic biopharma advisory. David is a FINRA-registered dealmaker specializing in both buy-side and sell-side M&A, offering deep expertise in structuring complex transactions that maximize shareholder value. His dual background in science and finance allows him to uniquely assess asset potential and navigate deal dynamics.
Corporate Accounting
Certified Public Accountant with more than 20 years’ experience serving the biotechnology - life sciences community. Resourceful and detail-oriented with proven experience in budgeting, financial reporting including, SEC filings (10K, 10Q and S-1), reviewing policies for the organization, developing internal control processes, reviewing contracts, and transitioning startup companies to successful merger, acquisition and IPO filings.
Marketing Effectiveness
Former Vice President at Sanofi with 25 years of leadership experience at Sanofi and Novartis. Expert in commercial execution, sales force effectiveness, field training, and designing high-impact omnichannel engagement strategies for product launches.
Market Access & Pricing
Global market access and pricing strategist with 25+ years of experience in commercial development, patient outcomes research and HE/HTA evidence generation. Deep expertise in patient journey research and resolving access friction points across US, EU, Japan, and APAC markets.
Corporate Finance & Investor Relations
With over 36 years of investment and advisory experience, Maureen brings a wealth of capital markets expertise. As a former sell-side research analyst and hedge fund portfolio manager, she specializes in guiding companies through IPO readiness, crafting compelling corporate narratives, and building sophisticated financial models to secure valuation. Proven record of supporting C-suite executives across biotechnology, healthcare services, and medtech companies. Strong in competitive positioning and company valuations.
Brand, Investor, Stakeholder Communications, Marketing
A digital marketing and brand strategy consultant with over 25 years of experience helping businesses - from startups to multinationals - build their online presence and grow revenue. Charles has served clients across healthcare, biotechnology, law, real estate, hospitality, and action sports, bringing a hands-on, results-driven approach to every engagement. Specializing in AI-powered SEO, WordPress development, paid media, and omni-channel strategy, delivering measurable improvements in lead generation and client retention.
Product, Clinical Development & Regulatory Strategy
Biotechnology executive and advisor with 20+ years of experience building platform biotech companies and creating clinical-stage assets across multiple therapeutic modalities. Experienced in aligning platform strategy, pipeline design, IP creation, and regulatory execution to drive clear value inflection points for investors and partners. Experience spans IND-enabling through Phase 3 development, global FDA/EMA engagement, and strategic pharmaceutical partnerships.
Digital Analytics, Clinical Development, Regulatory, GTM
Commercial strategy and corporate development executive with over 15 years of experience guiding life sciences and healthcare technology organizations through transformative growth. My career spans the full product lifecycle—from development and regulatory strategy to market access and commercialization—with a global perspective shaped by work across the US, Europe, Asia, and Australia. Whether supporting early-stage startups or working for global leaders like Genentech, Novartis, Oracle, Medidata and KomodoHealth, I’ve consistently aligned product innovation with market opportunity to drive impact at scale.
Corporate Strategy & Transactions
Corporate strategist and legal expert advising on complex transactions including IPOs, M&A, and licensing deals. Over 25 years of experience as a general counsel and member of senior leadership in public clinical and commercial stage biotech companies. Serves as a critical liaison between leadership teams, legal counsel, and investment bankers to streamline deal execution and align corporate strategy with regulatory requirements.
Focused guidance, executive workshops, and leadership sessions to align stakeholders on critical decisions.
Senior executive embedded within your team (e.g., Fractional CCO) to drive commercial execution without the overhead of a full-time hire.
End-to-end project delivery with a defined scope, timeline, and deliverables. Ideal for indication prioritization, TPP development, or market sizing.
Continuous advisory retainer tailored to evolving needs. Provides flexible access to our team's expertise as your company grows.
Biopharma companies do not need more adjectives. They need evidence-driven positioning that makes complex science understandable, credible, differentiated, and relevant to each audience.
Gain alignment among C Suite on organizations Goals, Challenges and unmet needs. Elect a sponsor to champion the assessment.
Before implementing any technology, good practice dictates a deep-dive Strategic Audit to assess readiness and commercial inflection points.
Identifying available clinical and real-world datasets and their compliance status.
Ranking opportunities by Commercial Materiality and probability of technical success.
Evaluating current internal capabilities vs. required vendor infrastructure.
Defining legal, regulatory, and GxP constraints early in the process.
Commercialization readiness begins when a company can define who will use the product, why it will win, how it will be paid for, what adoption barriers exist, and which evidence will change medical practice.
